A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel.
Makaleler > Tam Makale · 2013
Yazarlar: P MAISON-BLANCHE, JB VERMORKEN, Tuncay GÖKSEL, JP MACHIELS, S AGARWALA, S ROTTEY, G DAUGAARD, C VOLOVAT, M SCHEULEN, L SENGELØV, D GRECEA, A ENIU, E JÄGER, E MEIRI, S CASCINU, D STRUMBERG, Günay DEMİR, M CLEMENS, G PINOTTI, M NARDI, T GUTHRIE, E BOELLE, E MAGHERINI
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2013, cilt 61, ss 495-504